- A protein's binding site for a negatively charged ligand contains a critical lysine residue (Lys-84). A site-directed mutagenesis experiment replaces this lysine with an alanine residue. What is the most likely consequence of this K84A mutation on the protein's interaction with its ligand?
Answer: The dissociation constant (Kd) for the ligand will significantly increase, indicating weaker binding.
Lysine is positively charged at physiological pH and likely forms a critical salt bridge with the negatively charged ligand. Replacing it with alanine, a small, nonpolar amino acid, removes this favorable electrostatic interaction. The loss of this key interaction dramatically weakens the binding affinity, which is reflected as a large increase in the dissociation constant (Kd). Vmax relates to catalysis, not directly to initial binding affinity. A decrease in Kd means stronger binding. While specificity might be altered, the primary and most direct effect is on the affinity for the original ligand.
- Hexokinase has a high specificity for D-glucose. D-mannose is an epimer of D-glucose, differing only in the stereochemistry at the C2 carbon. Hexokinase can phosphorylate D-mannose, but at a much lower rate. What is the most plausible structural reason for this lower activity?
Answer: The axial position of the hydroxyl group at C2 of mannose sterically hinders the induced-fit conformational change of the enzyme.
Specificity arises from precise interactions. For hexokinase and glucose, the equatorial position of the C2 hydroxyl allows a perfect fit and facilitates the induced-fit clamping motion. In mannose, the C2 hydroxyl is axial. This minor change is enough to create a steric clash or disrupt a key interaction within the active site, preventing the enzyme from adopting its fully active conformation. This slows down catalysis. The other options are factually incorrect: both are primarily pyranoses, the difference is at C2 not C4, and mannose anomerizes freely.
- A regulatory protein has two distinct binding sites: one for its target DNA sequence (site A) and one for a small molecule effector (site B). Site B is located 25 Å away from site A. A mutation that disrupts site B reduces DNA binding affinity by 100-fold, even though site A remains structurally intact. Which mechanism most likely explains this long-range effect?
Answer: Allosteric coupling transmits conformational changes from site B to site A through the protein structure
The 25 Å distance rules out direct contact between sites, making allosteric coupling the most plausible mechanism. The effector binding likely stabilizes a conformation favorable for DNA binding. Choice A is incorrect due to distance. Choice C wouldn't require site B integrity. Choice D describes competition, not the observed cooperativity.
- Researchers are studying Protein P, which binds Ligand L. They find that in the absence of Molecule M, the Kd for Ligand L is 100 μM. When 1 mM of Molecule M is added, the Kd for Ligand L becomes 5 μM. Additional experiments show that Molecule M does not reduce the Vmax of an enzymatic reaction involving L and does not bind at the same site as Ligand L. What is the most accurate description of Molecule M's role?
Answer: Molecule M is a positive allosteric modulator of Protein P.
Molecule M causes the Kd for Ligand L to decrease significantly (from 100 μM to 5 μM). A lower Kd signifies higher binding affinity. Since Molecule M binds at a site distinct from the ligand binding site and positively influences ligand binding, it is by definition a positive allosteric modulator (or allosteric activator). It is not a competitive inhibitor because it binds at a different site and increases affinity. It is not a negative modulator because it increases affinity. It is not a denaturant, as that would abolish specific binding.
- An enzyme active site contains a catalytic triad with precise geometric requirements. A conservative mutation (Phe → Tyr) at a position 15 Å from the active site reduces catalytic efficiency (kcat/Km) by 50-fold while having minimal effect on substrate binding affinity. What is the most likely explanation for this effect?
Answer: The mutation disrupts a hydrogen bonding network that maintains optimal geometry for the catalytic mechanism
Since substrate binding is unaffected but catalysis is impaired, the mutation must disrupt catalytic geometry rather than substrate recognition. The 15 Å distance suggests an allosteric effect on active site organization. Choice A would affect binding affinity. Choice C would also affect binding. Choice D would dramatically reduce binding affinity.
- A metabolic enzyme is allosterically regulated by Activator A and Inhibitor I, which compete for binding at the same regulatory site. The enzyme is almost inactive without A and fully active when saturated with A. If the enzyme is in a solution containing concentrations of both A and I that are well above their respective dissociation constants, what will determine the enzyme's activity level?
Answer: The activity will depend on the relative binding affinities (Kd) of A and I for the regulatory site.
Since A and I bind competitively to the same allosteric site, the fractional occupancy of the site by A versus I will determine the enzyme's state. This occupancy is governed by the concentrations of A and I and their respective affinities (inversely related to Kd) for the site. If the affinity for I is much higher than for A, the enzyme will be mostly inhibited, and vice-versa. The activity will reflect this competitive equilibrium, not a fixed rule where one always dominates.
- An enzyme, phosphofructokinase-1 (PFK-1), is allosterically activated by fructose-2,6-bisphosphate (F2,6BP), a molecule that is structurally similar but distinct from the enzyme's substrates. Which statement most accurately describes the mechanism by which F2,6BP activates PFK-1?
Answer: F2,6BP binds to a regulatory site distinct from the active site, inducing a conformational change that stabilizes the high-affinity R-state.
Allosteric regulators function by binding to a site separate from the active (substrate-binding) site. This binding event triggers a conformational change that alters the protein's activity. For PFK-1, F2,6BP binds to an allosteric site and stabilizes the R-state (relaxed, high-activity, high-affinity for its substrate F6P), shifting the T/R equilibrium. It is not a cofactor, does not form a covalent bond, and while it does overcome ATP inhibition, it does so via the allosteric mechanism, not by direct competition at the substrate site.
- A hypothetical tetrameric transport protein exhibits positive cooperativity in binding its ligand. Which of the following is a necessary consequence of this property?
Answer: The binding of the first ligand molecule to one subunit increases the ligand affinity of the remaining unoccupied subunits.
Positive cooperativity is a form of homotropic allostery defined by the binding of a ligand to one site on a multi-subunit protein, which induces a conformational change that increases the binding affinity of the other sites for the same ligand. This communication between subunits is the core of cooperativity. The other options are incorrect: B describes the concerted (MWC) model but not a necessary consequence of cooperativity itself (sequential models exist), C describes heterotropic, not homotropic, regulation, and D is false as the individual subunits in the unliganded (T) state typically have low affinity.
- A transcriptional activator protein binds to DNA through a helix-turn-helix motif. When the protein concentration is increased from 1 nM to 100 nM, DNA binding increases from 10% to 90% occupancy. However, when a specific co-activator protein is present at 50 nM, 90% DNA occupancy is achieved at only 5 nM activator concentration. Which statement best explains this cooperative binding behavior?
Answer: The co-activator binds to DNA adjacent to the activator and increases the local effective concentration through protein-protein interactions
When you encounter questions about cooperative binding in transcriptional regulation, focus on how protein-protein interactions can dramatically enhance DNA binding affinity through proximity effects.
The dramatic shift in binding behavior—from requiring 100 nM activator for 90% occupancy to achieving the same occupancy at just 5 nM when the co-activator is present—indicates true cooperative binding. This occurs when the co-activator binds to an adjacent DNA site and forms stabilizing protein-protein interactions with the transcriptional activator. These interactions effectively increase the local concentration of the activator near its binding site, making it much more likely to bind and remain bound to DNA.
Option A is incorrect because competition with inhibitory factors would show a more gradual relief of inhibition, not the sharp cooperative effect observed. Option B incorrectly focuses on DNA structural changes rather than protein-protein interactions—the DNA accessibility would affect both conditions equally. Option C suggests the co-activator changes the activator's intrinsic binding properties, but true cooperative binding involves intermolecular interactions between proteins already bound to DNA, not conformational changes that alter intrinsic affinity.
The key study tip: Cooperative binding typically involves multiple proteins binding to adjacent sites and stabilizing each other through direct protein-protein contacts. Look for dramatic shifts in binding curves (like the 20-fold improvement here from 100 nM to 5 nM) as a hallmark of cooperativity, and remember that proximity effects through protein-protein interactions are the most common mechanism in transcriptional regulation.
- A protein kinase, PK-S, is activated by binding the second messenger molecule ZM. This binding not only increases PK-S's catalytic rate (kcat) but also significantly enhances its specificity for its primary substrate, Substrate-P, while reducing activity toward off-target proteins. Which structural mechanism best explains this dual effect of the allosteric activator ZM?
Answer: ZM binding induces a conformational change that simultaneously realigns catalytic residues and reshapes the substrate-binding pocket.
Allosteric regulation involves conformational changes that propagate through a protein's structure. A single binding event can trigger a complex rearrangement. In this case, the binding of ZM to its regulatory site can cause a shift that (1) moves catalytic residues into a more optimal position for phosphoryl transfer (increasing kcat) and (2) alters the active site's shape and chemical environment to favor unique contacts with Substrate-P and disfavor contacts with other proteins (increasing specificity). This integrated change is a hallmark of sophisticated allosteric control.
- A dimeric enzyme displays sigmoidal kinetics with respect to its substrate, indicating cooperative binding. A mutation is introduced at the interface between the two subunits, which disrupts the non-covalent interactions holding them together but does not affect the active site within each monomer. What is the most likely kinetic profile of this mutant enzyme compared to the wild-type?
Answer: The mutant will display hyperbolic (Michaelis-Menten) kinetics, and its apparent Km will be relatively high.
Sigmoidal kinetics are a hallmark of cooperativity, which requires communication between subunits. By disrupting the dimer interface, the mutation prevents this communication, so the subunits behave as independent monomers. An individual monomer follows Michaelis-Menten kinetics, producing a hyperbolic curve. Since communication allowing the shift from the low-affinity T-state to the high-affinity R-state is lost, the monomers will likely exhibit the low-affinity characteristics of the T-state, resulting in a relatively high apparent Km.
- A binding protein shows the following specificity pattern: tight binding to substrate A (Kd = 1 μM), moderate binding to substrate B (Kd = 50 μM), and no detectable binding to substrate C. Substrates A and B differ by a single methyl group, while C has an additional charged amino group. Based on this data, which feature of the binding site is most critical for substrate recognition?
Answer: A hydrogen bonding pattern that is optimized for substrate A, partially satisfied by B, but disrupted by the charged group in C
The 50-fold difference between A and B (single methyl group) suggests specific hydrogen bonding that's disrupted by the methyl substitution. Complete loss of binding to C indicates the charged amino group is incompatible, likely disrupting the hydrogen bonding network. Choice A would favor B over A. Choice B doesn't explain A vs B difference. Choice C doesn't account for the charge effect.
- A dimeric protein exhibits the following binding behavior: at low concentrations, it binds substrate with Kd = 100 μM per subunit. However, binding studies using analytical ultracentrifugation reveal that substrate binding promotes protein dimerization with a 10-fold increase in dimer stability. What would be the apparent Kd for substrate binding when the protein concentration is high enough to favor the dimeric state?
Answer: 100 μM, because the intrinsic binding affinity of each subunit remains unchanged regardless of the quaternary structure
The intrinsic Kd of each subunit for substrate remains 100 μM regardless of whether the protein is monomeric or dimeric. The increased dimer stability affects protein-protein interactions, not substrate binding affinity. The apparent Kd for substrate binding to individual sites doesn't change. Choices A and B incorrectly link dimerization to substrate affinity. Choice D incorrectly suggests energetic coupling reduces binding. - Aspartate transcarbamoylase (ATCase) is a key enzyme in pyrimidine biosynthesis that is allosterically inhibited by CTP, the final product of the pathway. How does CTP binding to ATCase lead to a decrease in enzyme activity?
Answer: CTP binds to the regulatory subunits, which stabilizes the low-activity, low-substrate-affinity T-state conformation of the enzyme.
ATCase has distinct catalytic and regulatory subunits. The allosteric inhibitor CTP binds to the regulatory subunits, not the active site. This binding event transmits a conformational change across the protein complex that stabilizes the tense (T) state. The T-state has lower affinity for the substrates (aspartate and carbamoyl phosphate), thus reducing the overall reaction rate. This is a classic example of feedback inhibition via heterotropic allosteric regulation.
- An allosteric enzyme has four identical subunits, each with one active site. In the absence of any effectors, the enzyme shows hyperbolic kinetics. Addition of effector X converts the kinetics to sigmoidal with increased activity, while effector Y maintains hyperbolic kinetics but decreases overall activity. Which statement best describes the mechanism of these effectors?
Answer: Effector X promotes positive cooperativity and increases intrinsic activity, while effector Y decreases intrinsic activity without inducing cooperativity
Effector X converts hyperbolic to sigmoidal kinetics (indicating positive cooperativity) and increases activity. Effector Y decreases activity but maintains hyperbolic kinetics (no cooperativity change). Choice A incorrectly calls Y competitive. Choice B incorrectly describes X as negative cooperativity. Choice D doesn't explain the different kinetic patterns.
- A dimeric enzyme exhibits cooperative binding for its substrate. When one subunit binds substrate, it increases the binding affinity of the second subunit by a factor of 10. If the intrinsic dissociation constant (Kd) for substrate binding to an isolated subunit is 100 μM, what is the apparent Kd for the second binding event in the intact dimer?
Answer: 10 μM, because cooperative binding decreases the dissociation constant proportionally to the cooperativity factor
When cooperative binding increases binding affinity by a factor of 10, the dissociation constant decreases by the same factor (since Kd=1/Ka). Therefore, 100 μM ÷ 10 = 10 μM. Choice B incorrectly applies square root scaling. Choice C ignores the cooperative effect. Choice D incorrectly suggests positive cooperativity decreases affinity. - An enzyme's active site is initially in an open conformation. Upon binding of its specific substrate, two domains of the enzyme clamp down, enclosing the substrate in a new, catalytically competent conformation and excluding water molecules. This mechanism is an example of the induced-fit model. What is a primary functional advantage of this binding mechanism?
Answer: It ensures high specificity by forming optimal transition-state stabilizing interactions only after the correct substrate is bound.
The induced-fit model proposes that the enzyme's active site is flexible and changes shape to best accommodate the substrate. A key advantage is that the final, highly active conformation is only achieved with the correct substrate. This process of conformational change positions catalytic groups correctly and stabilizes the reaction's transition state, which is a major source of catalytic power and specificity. It prevents the enzyme from wasting catalytic effort on incorrect substrates. The change is reversible, not permanent.
- A specific mutation in the allosteric site of liver glycogen phosphorylase causes it to be constitutively active, regardless of the cellular levels of its normal allosteric inhibitors, ATP and glucose-6-phosphate. What would be the most likely physiological consequence in a liver cell containing this mutated enzyme?
Answer: Uncontrolled glycogenolysis, leading to depletion of glycogen stores and excessive glucose release even in a well-fed state.
Glycogen phosphorylase breaks down glycogen. Its activity is tightly regulated to occur during fasting/energy demand and be shut off during energy abundance (inhibited by ATP, G6P). A constitutively active mutant would ignore these 'stop' signals. In the liver, this would lead to continuous breakdown of glycogen and release of glucose into the blood, even when blood glucose is high, which is metabolically wasteful and can lead to hyperglycemia.
- The binding site of a protease is a deep, narrow pocket. The bottom of the pocket contains an aspartate residue (Asp-102), and the walls are lined with hydrophobic residues like valine and leucine. To be a highly specific and potent competitive inhibitor, a small molecule should ideally possess which combination of features?
Answer: A long, hydrophobic alkyl chain and a terminal, positively charged amino group.
A potent and specific inhibitor should maximize favorable interactions with the binding site. The long, hydrophobic chain would fit into the narrow, hydrophobic pocket via van der Waals interactions. The terminal, positively charged amino group would form a strong, favorable salt bridge (ionic interaction) with the negatively charged aspartate residue at the bottom of the pocket. This combination of interactions confers both high affinity and specificity.
- Two related kinases, Kinase A and Kinase B, both phosphorylate Protein X. Kinase A has a Kd of 10 nM for Protein X, while Kinase B has a Kd of 500 nM for Protein X. However, Kinase B exclusively phosphorylates Protein X, whereas Kinase A is also observed to phosphorylate Proteins Y and Z. Based on this information, which conclusion is best supported?
Answer: Kinase A exhibits higher affinity for Protein X, but Kinase B exhibits higher substrate specificity.
Affinity is inversely related to the dissociation constant (Kd). A lower Kd means higher affinity. Therefore, Kinase A (Kd=10 nM) has a higher affinity for Protein X than Kinase B (Kd=500 nM). Specificity refers to the ability to discriminate between different potential substrates. Since Kinase B only phosphorylates Protein X while Kinase A acts on three different proteins, Kinase B is more specific. No information about kcat is given.
